Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (5): 318-318.
Previous Articles Next Articles
WANG han,TIAN Chun-xiang,JIANG Yong-xian ,LIANG Hua ,LI gen
Received:2018-01-19
Revised:2018-06-21
Online:2018-05-20
Published:2018-06-21
Contact:
李根,男,本科,主任药师,临床药学和药事管理。E-mial：627045226@qq.com
CLC Number:
WANG han,TIAN Chun-xiang,JIANG Yong-xian ,LIANG Hua ,LI gen. One Case of Thrombocytopenia Induced by Indapamine Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 318-318.
| [1] 周群. 吲达帕胺致剥脱性皮炎并血小板减少1例[J]. 中国医药药学杂志，2012, 32（13）：1073-1073. [2] 杨华, 魏晶, 王嘉仡, 等. 药品不良反应 / 事件报告评价方法研究[J]. 中国药物警戒, 2009, 6(10): 581-584. [3] 国家食品药品监督管理局药品安全监管司，国家药品不良反应中心. 药品不良反应报告和监测工作手册[S].2005: 46. [4] Grosbois B, Milton D, Beneton C, et al.Thrombocytopenia induced by angiotensin converting enzyme inhibitors[J].BMJ, 1989, 298(6667): 189-190. [5] 邹敬伟, 李中东, 邹英华. 达帕胺不良反应的回顾性分析[J].中国新药与临床杂志, 2006, 25(6):477-479. [6] 郭晶.20例吲达帕胺不良反应分析[J]. 中国卫生标准管理，2015，6（5）：262-263. [7] 郭永芳, 王钟林. 吲达帕胺的降压机制及心血管保护作用[J]. 天津药学, 1998 ,10(4): 1-6. [8] Yan X W. The effect of indapamide on plasma prostaglandins in hypertensive patients[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 1992, 20(6): 345-6, 388-9. [9] Campbell D B, Brackman F. Cardiovascular protective properties of indapamide[J]. Am J Cardiol, 1990, 65(17): 11H-27H. [10] Rendu F, Bachelot C, Molle D, et al.Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide[J]. J Cardiovasc Pharmacol, 1993, 22(6) : S57-63. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
